News

While an adverse event reported in Intellia’s gene therapy trial was a “non-concern” for analysts, it follows a handful of ...
The canceled contract comes as Moderna nears a critical FDA decision for its next-generation COVID-19 vaccine.
Patritumab deruxtecan was unable to significantly improve overall survival in patients with locally advanced or metastatic ...
Looking for a biopharma job in New York? Check out the BioSpace list of seven companies hiring life sciences professionals ...
Teos expects to absorb nearly $25 million in one-time costs for severance and termination payments. The biotech had 173 ...
In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...
It’s called the peak-end rule. People remember two things most about an experience: the most emotionally intense moment and ...
Nearly a third of employed and almost half of unemployed BioSpace survey respondents are seriously considering leaving the ...